Coronado Forms DiaVax for Vaccines research $CNDO $XHS

Coronado Biosciences, Inc., has a formed a new sub company DiaVax Biosciences, to develop novel immuno- therapies for the prevention and treatment of cytomegalovirus (CMV).

View the full release here.